NCT04537676

Brief Summary

The Patient Empowerment Study is an observational longitudinal study among adults with diabetic foot ulcer (DFU). The scope of this study is to better understand how a patient's DFU disease process and usage of the Podimetrics System can impact patient health-related quality of life. Health-related quality of life will be measured by both the generic 36-item Short-Form Health Survey (SF-36) questionnaire and the ulcer-specific Diabetic Foot Ulcer Scale Short Form (DFS-SF) questionnaire.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 3, 2020

Completed
12 days until next milestone

Study Start

First participant enrolled

September 15, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

September 3, 2020

Status Verified

August 1, 2020

Enrollment Period

1.1 years

First QC Date

August 28, 2020

Last Update Submit

September 2, 2020

Conditions

Keywords

Diabetic FootQuality of LifeFoot Ulcer

Outcome Measures

Primary Outcomes (2)

  • Quality of Life Score (generic)

    Quality of Life will be measured by the Medical Outcomes Study 36-item Short-Form Questionnaire (SF-36). This questionnaire addresses general quality of life issues.

    At 12-month after recruitment

  • Quality of Life Score (ulcer-specific)

    Quality of Life will also be measured by theDiabetic Foot Ulcer Scale Short Form (DFS-SF). This questionnaire addresses issues specific to diabetic foot diseases, such as ulcer severity and impact of ulcer care.

    At 12-month after recruitment

Study Arms (1)

DFU Participants

A cohort of 200 DFU patients who have been prescribed the Podimetrics System by their healthcare providers will be recruited upon providing informed consent. Potential participants will be asked to indicate their interest in participating in this patient empowerment study during their initial phone consultation for mat set-up with the Podimetrics care-management team. Participants will be followed for one year and answer a set of identical questionnaires at three time points: at baseline, at 6-month and at 12-month post enrollment.

Other: No intervention, this is an observational study

Interventions

No intervention

DFU Participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Two hundred (200) patients who have been prescribed the Podimetrics Remote Temperature Monitoring System (hereafter "Podimetrics System") by their healthcare providers will be recruited. Potential participants will be asked to indicate their interest in participating in this patient empowerment study during their initial phone consultation for mat set-up with the Podimetrics care-management team. Participants will be recruited based on the requirements indicated below. A Podimetrics representative will confirm that each participant meets the requirements by evaluation through a brief interview after participants indicate their interest and provide oral consent. This study will exclude anyone with a cognitive impairment that would disqualify them from providing informed consent.

You may qualify if:

  • Be at least 18 years old (by verbal history from the participant)
  • Have history of one or more foot ulcers in the lower extremities (by verbal history from the participant)
  • Have been prescribed the Podimetrics RTM System in the last 30 days
  • Not be pregnant (by verbal history from the participant)
  • Be mentally lucid
  • Be able to read and write English
  • Provide informed consent

You may not qualify if:

  • Be younger than 18 years old
  • Unable to understand English
  • Unable to complete questionnaires due to visual or upper extremity impairments
  • Unable to provide consent
  • Other issues that, at the discretion of the investigator, renders the subject ineligible for participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Podimetrics,Inc.

Somerville, Massachusetts, 02144, United States

Location

MeSH Terms

Conditions

Diabetic FootFoot UlcerDiabetes Complications

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes MellitusEndocrine System DiseasesDiabetic NeuropathiesFoot Diseases

Central Study Contacts

Brian J Petersen

CONTACT

Abbie Liu

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2020

First Posted

September 3, 2020

Study Start

September 15, 2020

Primary Completion

October 15, 2021

Study Completion

March 1, 2022

Last Updated

September 3, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

To protect participant identity, names will not be recorded as part of this study. Instead, each participant will be assigned a unique identifier. Any identifiable data will not be associated with the information collected by the questionnaires.

Locations